Navigation Links
Stereotaxis Introduces New Electrophysiology Platform: Epoch™
Date:4/27/2011

ST. LOUIS, April 27, 2011 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) today announces the introduction of its new Stereotaxis Epoch™  platform, a comprehensive solution for any electrophysiology lab which combines the recognized benefits of remote magnetic catheter control, the efficiency of remote robotic device manipulation, and the power of the Odyssey platform, enabling highly sophisticated procedural data integration and transmission.  The Epoch™ platform will be unveiled at the annual Heart Rhythm Society meeting May 5-7, 2011 in San Francisco, CA.

The Stereotaxis Epoch solution is the beginning of a new modular platform designed to meet the broad range of clinical needs physicians face today and in the future.  Building on the strength of Magnetic Navigation's exceptional safety profile and significant radiation reduction, the Epoch platform features the latest technological breakthroughs in Magnetic Navigation, which will lead to faster, more efficient, and dynamic magnetic catheter control.  In addition, the Epoch platform will seamlessly integrate Stereotaxis' Vdrive™ mechanical robotic platform for remote manipulation of a growing array of devices, such as loop diagnostic catheter and sheath.  

The Epoch solution delivers value well beyond the lab with the power of Stereotaxis' Odyssey™ solution–an unprecedented offering which integrates the complex array of clinical data into synchronized, high-definition view delivering real-time clinical information anywhere at physicians' fingertips.  The Odyssey solution empowers hospital executives to drive initiatives which improve care, enhance performance, and increase referrals and market services throughout global communities.    

"We are excited to introduce our Epoch solutions to the EP market as we are committed to developing solutions that meet the most critical needs of our customers, while supporting any preferred clinical treatment technique," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis. "Early feedback from key opinion leaders suggests that the Epoch platform enables us to deliver a much more efficient and enhanced EP workflow while maintaining our excellent profile in safety, radiation reduction and clinical outcome."

Stereotaxis expects that the Stereotaxis Epoch solutions will significantly reduce procedure time for all types of robotic-assisted EP procedures, especially for atrial fibrillation ablation procedures.  In addition, user learning curve will be accelerated as a result of automated scripting of expert users' navigation techniques.  Furthermore, labs equipped with the Vdrive module can benefit from optimized and full remote navigation and control of devices such as loop diagnostic catheters and sheaths.

While customers in EU markets already have commercial access to the Vdrive module, Vdrive is currently under FDA 510(k) review prior to its commercial availability in the U.S. market.  

About Stereotaxis             www.stereotaxis.com         www.odysseyexperience.com

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure.

Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and around the world. The Odyssey™ Vision integrates data for magnetic and standard interventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. The Odyssey™ Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed.  The Odyssey™ solution then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to maximize referrals and promote collaboration.

The core components of the Stereotaxis systems have received regulatory clearance in the U.S., Europe, Canada and elsewhere. For more information, please visit www.stereotaxis.com and www.odysseyexperience.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to,  continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase our systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified, delayed or canceled, either by their express terms, as a result of negotiations, or by overall project changes or delays.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Stereotaxis Announces Public Offering of Common Stock
4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Installs First System in Taiwan
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... birth tissues, human skin and bone, and patent-protected processes ... and therapies, announced today that it will present at ... New York , NY.  Parker H. ... , Chief Financial Officer and Chris Cashman , ...
(Date:2/11/2016)... WESTPORT, Conn. , Feb. 11, 2016  AfterPill.com ... decision to recommend alcohol abstinence for all women who ... women in the U.S. each year and raises the ... --> --> According to the ... U.S., 70% of women of child-bearing age, who have ...
(Date:2/11/2016)... Feb. 11, 2016 Wearable posture tracker, ALEX , has taken Kickstarter by storm, crowdfunding ... seven days left to go, ALEX is said to be delivered to backers starting May of this ... ... ... Created by NAMU, a ...
Breaking Medicine Technology:
(Date:2/14/2016)... ... February 14, 2016 , ... In ... Heart Failure Nurses (AAHFN) is promoting healthier living with heart failure by providing ... Life! Healthy Living with Heart Failure will kick-off February 14 and includes tips ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... Many individuals ... of protein for a multitude of reasons. IsoPasta by Isolator Fitness has delved ... it once more, but without the high-carb repercussions. IsoPasta has 30 grams of ...
(Date:2/13/2016)... ... ... an Au Pair comes all the way around the world to provide child ... are often worried things won’t go well. More often than not, however, they find out ... the Year winner’s all commented how their Au Pairs have become a part of the ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... ... February 12, 2016 , ... Each year, the American Physical Therapy ... Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists across the country ... in action, learn more about their chosen field and network with their colleagues. ...
Breaking Medicine News(10 mins):